share_log

国邦医药(605507.SH)：2023年净利润同比下降33.49% 拟10派3元

Guobang Pharmaceutical (605507.SH): Net profit in 2023 fell 33.49% year on year, and plans to pay 10 to 3 yuan

Gelonghui Finance ·  Apr 15 06:55

On April 15, Ge Longhui Pharmaceutical (605507.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 5.349 billion yuan, a year-on-year decrease of 6.49%; net profit attributable to shareholders of listed companies was 612 million yuan, a year-on-year decrease of 33.49%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 592 million yuan, a year-on-year decrease of 34.69%; and basic earnings per share were 1.10 yuan. It is proposed to distribute a cash dividend of RMB 3.00 (tax included) for every 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment